IP Library Assignment 055524/0173
Patent Assignment
Reel/Frame 055524/0173

Assignment of Assignor's Interest

Recorded: 2021-03-08 Pages: 14
Assignors
COSSROW, JENNIFER
Executed: 2008-07-07
RAIMUNDO, BRIAN C.
Executed: 2008-07-08
TANAKA, HIROKO
Executed: 2008-07-08
Assignee
SUNESIS PHARMACEUTICALS, INC.
341 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,802,657 →
Application: 13/657,506 →
Publication: US 2013/0065858
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0863 →
Assignment of Assignor's Interest Mar 8, 2021
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 055524/0371 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0457 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 055524/0525 →
Merger May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →